121 related articles for article (PubMed ID: 37635063)
1. Local Delivery of Nimustine Hydrochloride against Brain Tumors: Basic Characterization Study.
Shao X; Saito R; Sato A; Okuno S; Saigusa D; Saito R; Uruno A; Osada Y; Kanamori M; Tominaga T
Tohoku J Exp Med; 2023 Nov; 261(3):187-194. PubMed ID: 37635063
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of convection-enhanced delivery of ACNU, a hydrophilic nitrosourea, in intracranial brain tumor models.
Sugiyama S; Yamashita Y; Kikuchi T; Saito R; Kumabe T; Tominaga T
J Neurooncol; 2007 Mar; 82(1):41-7. PubMed ID: 17031554
[TBL] [Abstract][Full Text] [Related]
3. Safety and feasibility of convection-enhanced delivery of nimustine hydrochloride co-infused with free gadolinium for real-time monitoring in the primate brain.
Sugiyama S; Saito R; Nakamura T; Yamashita Y; Yokosawa M; Sonoda Y; Kumabe T; Watanabe M; Tominaga T
Neurol Res; 2012 Jul; 34(6):581-7. PubMed ID: 22709625
[TBL] [Abstract][Full Text] [Related]
4. Convection-enhanced delivery of a hydrophilic nitrosourea ameliorates deficits and suppresses tumor growth in experimental spinal cord glioma models.
Ogita S; Endo T; Sugiyama S; Saito R; Inoue T; Sumiyoshi A; Nonaka H; Kawashima R; Sonoda Y; Tominaga T
Acta Neurochir (Wien); 2017 May; 159(5):939-946. PubMed ID: 28247160
[TBL] [Abstract][Full Text] [Related]
5. Enhanced antitumor effect of combined-modality treatment using convection-enhanced delivery of hydrophilic nitrosourea with irradiation or systemic administration of temozolomide in intracranial brain tumor xenografts.
Sugiyama S; Yamashita Y; Kikuchi T; Sonoda Y; Kumabe T; Tominaga T
Neurol Res; 2008 Nov; 30(9):960-7. PubMed ID: 18671903
[TBL] [Abstract][Full Text] [Related]
6. Concentration rather than dose defines the local brain toxicity of agents that are effectively distributed by convection-enhanced delivery.
Zhang R; Saito R; Mano Y; Kanamori M; Sonoda Y; Kumabe T; Tominaga T
J Neurosci Methods; 2014 Jan; 222():131-7. PubMed ID: 24269253
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial of convection-enhanced delivery of nimustine hydrochloride (ACNU) for brainstem recurrent glioma.
Saito R; Kanamori M; Sonoda Y; Yamashita Y; Nagamatsu K; Murata T; Mugikura S; Kumabe T; Wembacher-Schröder E; Thomson R; Tominaga T
Neurooncol Adv; 2020; 2(1):vdaa033. PubMed ID: 32642691
[TBL] [Abstract][Full Text] [Related]
8. Regression of Recurrent Spinal Cord High-Grade Glioma After Convection-Enhanced Delivery of Nimustine Hydrochloride: Case Reports and Literature Review.
Endo T; Inoue T; Sugiyama S; Saito R; Tominaga T
Oper Neurosurg (Hagerstown); 2020 Apr; 18(4):451-459. PubMed ID: 31414134
[TBL] [Abstract][Full Text] [Related]
9. Convection-enhanced delivery of SN-38-loaded polymeric micelles (NK012) enables consistent distribution of SN-38 and is effective against rodent intracranial brain tumor models.
Zhang R; Saito R; Mano Y; Sumiyoshi A; Kanamori M; Sonoda Y; Kawashima R; Tominaga T
Drug Deliv; 2016 Oct; 23(8):2780-2786. PubMed ID: 26330269
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the mechanism of ACNU resistance in sublines of rat C6 glioma and 9L gliosarcoma in vitro].
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Kato A; Mogami H; Sakamoto Y
No Shinkei Geka; 1986 Oct; 14(11):1299-304. PubMed ID: 3468375
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic efficacy of intracarotid infusion of 20% mannitol with ACNU in Fischer rats with intracerebrally implanted 9L gliosarcoma].
Miyagami M; Tazoe M; Kasahara E; Tsubokawa T
Gan To Kagaku Ryoho; 1989 May; 16(5):2059-65. PubMed ID: 2499268
[TBL] [Abstract][Full Text] [Related]
12. Isolation and preliminary characterization of ACNU-resistant sublines of rat brain tumors in vivo.
Yoshida TK; Shimizu K; Koulousakis A; Sturm V; Beuls E
J Neurosurg; 1992 Sep; 77(3):451-6. PubMed ID: 1506893
[TBL] [Abstract][Full Text] [Related]
13. In vitro sensitivity of nitrosourea-induced neurogenic tumors to ACNU.
Kida Y; Cravioto H; Hochwald G; Ransohoff J
Anticancer Res; 1982; 2(1-2):79-87. PubMed ID: 6956245
[TBL] [Abstract][Full Text] [Related]
14. Local convection-enhanced delivery of chemotherapeutic agent transiently opens blood-brain barrier and improves efficacy of systemic chemotherapy in intracranial xenograft tumor model.
Nakamura T; Saito R; Sugiyama S; Sonoda Y; Kumabe T; Tominaga T
Cancer Lett; 2011 Nov; 310(1):77-83. PubMed ID: 21763069
[TBL] [Abstract][Full Text] [Related]
15. Convection-enhanced delivery of polyethylene glycol-coated liposomal doxorubicin: characterization and efficacy in rat intracranial glioma models.
Kikuchi T; Saito R; Sugiyama S; Yamashita Y; Kumabe T; Krauze M; Bankiewicz K; Tominaga T
J Neurosurg; 2008 Nov; 109(5):867-73. PubMed ID: 18976076
[TBL] [Abstract][Full Text] [Related]
16. Convection-enhanced Delivery of Therapeutics for Malignant Gliomas.
Saito R; Tominaga T
Neurol Med Chir (Tokyo); 2017 Jan; 57(1):8-16. PubMed ID: 27980285
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats.
Degen JW; Walbridge S; Vortmeyer AO; Oldfield EH; Lonser RR
J Neurosurg; 2003 Nov; 99(5):893-8. PubMed ID: 14609170
[TBL] [Abstract][Full Text] [Related]
18. [Development of ACNU-resistant meningeal gliomatosis models: establishment of resistant rat glioma subline against ACNU].
Yoshida T; Ushio Y; Hayakawa T; Yamada K; Kato A; Mogami H; Nakata Y
No Shinkei Geka; 1984 Aug; 12(9):1029-36. PubMed ID: 6594599
[TBL] [Abstract][Full Text] [Related]
19. The mechanism and overcoming of resistance in ACNU-resistant sublines of C6 and 9L rat glioma.
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Mogami H; Sakamoto Y
J Neurooncol; 1987; 5(3):195-203. PubMed ID: 3479534
[TBL] [Abstract][Full Text] [Related]
20. ACNU-resistant mutants of 9L rat glioma cell line. Isolation and preliminary characterization of these subclones.
Kokunai T; Tamaki N; Matsumoto S
J Neurosurg; 1985 Oct; 63(4):583-8. PubMed ID: 3861792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
